BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Laser capture microdissection
,
Cisplatin
,
rs2476601
,
PBX1
,
Ischemia
,
Breast
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
H3 receptor
Summary
General Info
Curated Studies
Most Correlated Studies
Broad Connectivity Map (CMAP 2.0) compound database
Breast MCF7/BUS cells overexpressing ESR1 Y537S or D538G mutation and with raloxifene or fulvestrant
Breast adenocarcinoma MCF7 cells treated with tamoxifen, fulvestrant or H3B-5942
Endometrial cancer Ishikawa cells treated with estrogen receptor covalent antagonist H3B-5924
Adenocarcinoma of breast MCF7 cells treated with Tamoxifen, Fulvestrant, H3B-6545, and H3B-9709
Explore Curated Studies Results
Literature
Most Relevant Literature
The histamine H3R and dopamine D2R/D3R antagonist ST-713 ameliorates autism-like behavioral features…
Therapeutic Potential of Histamine H3 Receptors in Substance Use Disorders.
Histamine H3 receptor function and ligands: recent developments.
Postsynaptic histamine H3 receptors in ventral basal forebrain cholinergic neurons modulate contextu…
Imaging Histamine H3 Receptors with Positron Emission Tomography.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Clinical Study on Histamine H3 Receptor Occupancy of TS-091 by PET Examination in Healthy Adult Subj…
Evaluation of Histamine H3 Receptor Radioligand [11C]AZ12807110 and Histamine H3 Receptor Occupancy …
Loc3CAR: Locoregional Delivery of B7-H3-CAR T Cells for Pediatric Patients With Primary CNS Tumors
TAA06 Injection in the Treatment of Patients With B7-H3-positive Relapsed/ Refractory Neuroblastoma
Genetically Modified Cells (KIND T Cells) for the Treatment of HLA-A*0201-Positive Patients With H3.…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ